ロード中...
Severe hypercalcemia due to teriparatide
Osteoporosis that is by far the most common metabolic bone disease, has been defined as a skeletal disorder characterized by compromised bone strength predisposing a person to an increased risk of fracture. Anabolic therapy with teriparatide, recombinant human parathyroid hormone (PTH 1-34), stimula...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3326929/ https://ncbi.nlm.nih.gov/pubmed/22529492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.93869 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|